Medically reviewed by Sanja Jelic, MD Asthma and chronic obstructive pulmonary disease (COPD) are chronic respiratory (lung) ...

Historically, RSV has been studied mainly in infants and older adults, but recent research shows that it also poses a ...

The European Medicines Agency will review GSK's request to approve its asthma drug Nucala as an additional treatment for ...

As with asthma, people with COPD may experience coughing and shortness of breath. But morning coughing with phlegm is more characteristic of COPD. In contrast, asthma tends to cause worsening ...

Nov. 27, 2024 — A recent trial finds an injection given during some asthma and COPD attacks is more effective than the current treatment of steroid tablets, reducing the need for further ...

A remote monitoring program predicted when patients with asthma would experience distress, according to a poster presented at ...

Following recent approvals in the EU, China and the U.S., this approval was based on pivotal Phase 3 results in adults with elevated eosinophils ...

Dupixent (dupilumab) is available in Japan in a 300 mg dose as a pre-filled syringe or pre-filled pen and is now available ...

The global COPD and asthma diagnostic and monitoring device market accounted for $4,953.60 million in 2019, and is expected to reach $8,202.62 million by 2027, registering a CAGR of 6.3% from 2020 to ...